To improve health globally through discovery research and the prevention, treatment and cure of infectious diseases.
22 Jun 2022
Evolution in action as hundreds of hospital superbug golden staph infections mappedHigh-resolution genome mapping of the antibiotic-resistant 'golden staph' hospital superbug has revealed the many mutations these dangerous bacteria …
22 Jun 2022
Setting it Straight: From acute COVID disease phase to recovery, or Long COVID
15 Jun 2022
Professor Peter Revill receives Queen’s Birthday Honour
09 Jun 2022
Unvaccinated children mount COVID-19 immune response, but vaccination may be key to strengthening immunity
This study will be looking at two different vaccines for prevention of COVID-19 infection. Both vaccines are locally made in Australia. The vaccines are a recombinant protein vaccine (similar to the Novavax vaccine) and an mRNA vaccine (similar to Pfizer or Moderna COVID-19 vaccines). To participate in the trial contact firstname.lastname@example.org or call 8344 9325.
Are you going to get your first, second or ‘booster’ COVID-19 vaccine? We are looking for a wide selection of Victorians to contribute samples to the Victorian COVID-19 Vaccinees Collection.
This publication highlights the Doherty Institute's collaborations and work with Aboriginal and Torres Strait Islander (Indigenous) people and communities. In 2022, we aim to expand the Doherty Institute’s collaborations and work with Indigenous people and communities to address the needs of Indigenous communities.
Meet our people
Our people are at the forefront of research, teaching, public health and reference laboratory services, diagnostic services and clinical care in infectious diseases and immunity.